When administered for 48 weeks, the SGLT2 inhibitor dapagliflozin alleviated steatohepatitis and fibrosis in patients with metabolic dysfunction-associated steatohepatitis (MASH) while demonstrating a ...

Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB ("Ribo", HKEX: 6938) today announced the achievement of a further milestone. This marks the third key milestone achieved in the ...

The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows improvements for patients with progressive liver disease, finds a clinical ...

A diabetes drug may soon double as a treatment for liver disease. Dapagliflozin, an SGLT-2 inhibitor typically used for type 2 diabetes, significantly improved liver inflammation and scarring in ...

The FDA expanded the indication for semaglutide (Wegovy) to treating adults with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), the agency announced. The glucagon-like peptide-1 ...

Does Fatty Liver Lead to Cirrhosis ? Fatty liver disease, now called steatotic liver disease, happens when too much fat builds up in your liver. Over time, this extra fat can cause inflammation and ...

What Is Metabolic Dysfunction-Associated Steatohepatitis? Metabolic dysfunction-associated steatohepatitis, or MASH, is a form of liver disease. MASH occurs when fat accumulates in liver cells. Plenty ...

The study also found that the benefit plateaued at just one visit per year. That’s an accessible, low-bar intervention.

Drinking 2-3 cups of black coffee daily may lower the risk of liver fibrosis and cirrhosis by 25-40%. Coffee’s antioxidants ...